|
Market Closed -
Nasdaq
23:00:00 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 38.06 USD | +3.76% |
|
+6.82% | +16.28% |
| 10-12 | BofA Securities Initiates Axogen at Buy, $52 Price Target | MT |
| 10-07 | Barclays Initiates Coverage on Axogen With Overweight Rating, $55 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.15B | - | - | - | ||
| 250B | |||||
| 162B | |||||
| 154B | |||||
| 66.68B | |||||
| 52.08B |
- Stock Market
- Stocks
- AXGN Stock
- Charts Axogen, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
